The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.
Lodi, S., Fisher, M., Phillips, A., DE LUCA, A., Ghosn, J., Malyuta, R., et al. (2013). Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection. PLOS ONE, 8(11), e78642-e78642 [10.1371/journal.pone.0078642].
Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection
DE LUCA, ANDREA;
2013-01-01
Abstract
The risk/benefit of initiating ART in primary HIV infection (PHI) is unclear. The benefits are more likely to outweigh the risks in patients with severe PHI. An accepted definition of severe PHI is, however, lacking.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/1011835
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo